The nifty Support level is placed at 11745 followed by 11675. If Nifty starts going up, then the resistance level will be 11850 and 11910. While the Bank Nifty support level is placed at 25200 and 24800. If Bank Nifty starts going up, then the resistance level will be 25975 and 26200.
FII and DII data
Foreign Institutional Investors bought shares of Rs. 2274.40 crore while Domestic Institutional Investors sold shares of Rs. 1100.92 crore in Indian equity market on November 03, as per data NSE data.
F&O Ban on NSE
No security is under the F&O ban for tomorrow (Nov 04).
Latest Corporate Action
- Adani Ports Limited – Q2 Profit at Rs. 1393.69 crores versus Rs. 1059.20 crores, Revenue at Rs. 2902.52 crores versus Rs. 2821.16 crores, Other Income at Rs. 520.64 crores versus Rs. 505.74 crores YoY (Good Result).
- BLS International Services Limited – Q2 Profit at Rs.1388.07 lakhs versus Rs. 95.98 lakhs, Revenue at Rs. 13122.84 lakhs versus Rs. 20359.02 lakhs, Other Income at Rs. 369.91 lakhs Profit versus Rs. 143.62 lakhs YoY (Good Result).
- Care Ratings Limited – Q2 Profit at Rs.3584.32 lakhs versus Rs. 3672.72 lakhs, Revenue at Rs. 7587.94 lakhs versus Rs. 7162.88 lakhs, Other Income at Rs. 799.48 lakhs Profit versus Rs. 908.65 lakhs YoY (Good Result).
- Everest Industries Limited – Q2 Profit at Rs.1744 lakhs versus Rs. 644 lakhs loss, Revenue at Rs. 27193 lakhs versus Rs. 28632 lakhs, Other Income at Rs. 353 lakhs Profit versus Rs. 247 lakhs YoY (Mix Result).
- Godrej Industries Limited – Crisil Rating has given its outlook on the rating that has undergone revision to CRISIL A1+ with stable implications, maintaining an Issue of commercial paper.
- Ramco System Limited – Q2 Profit at Rs. 83.52 millions versus Rs. 150.77 millions, Revenue at Rs. 828.39 millions versus Rs. 821.71 millions, Other Income at Rs. 26.27 millions Profit versus Rs. 27.97 millions YoY (Negative Result).
- Prince Pipes Limited – Q2 Profit at Rs. 465.72 millions versus Rs. 334.12 millions, Revenue at Rs. 4586.65 millions versus Rs. 4292.31 millions, Other Income at Rs. 32.80 millions Profit versus Rs. 05.86 millions YoY (Good Result).
- Ajanta Pharma Limited – Q2 Profit at Rs. 225.22 crores versus Rs. 120.70 crores, Revenue at Rs. 676.51 crores versus Rs. 559.45 crores, Other Income at Rs. 86.24 crores versus Rs. 39.31 crores YoY. Declared interim dividend of Rs. 09.50/- per share and Buyback Approved at 1850/- per share (Excellent Result).
Board Meeting on 04 November 20
Adani Enterprises, SBI, Pidilite Industries, Lupin, HPCL, Indian Hotels will decalred their Q2FY21 results on 04 November.
Leave a Reply